Learn how to evaluate and treat patients with obesity with emerging incretin-based therapies to improve long-term weight loss and reduce the risk of obesity-related complications.
In this commentary, an expert on obesity management answers questions on GLP-1 receptor agonist dosing, the use of supplemental weight-loss pharmacotherapy along with a GLP-1 receptor agonist, and more from the live webinar, “Obesity Management Strategies That Can Reap the Benefits of Long-term Weight Loss”
In this commentary, an expert in obesity answers questions on the duration of weight loss pharmacotherapy, the role of metabolic adaptation in weight regain after bariatric surgery, and how to increase brain-derived neurotrophic factor, from the live webinar, “Obesity Management Strategies That Can Reap the Benefits of Long-term Weight Loss.”
Here’s my take on the importance of close monitoring of your patients with obesity to maintain a healthy weight for risk reduction of cardiometabolic complications
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.